Combined antioxidants and anti-inflammatory therapies fail to attenuate the early and late phases of cyclodextrin-induced cochlear damage and hearing loss
A major side effect of using high doses of HPβCD to treat Niemann Pick type C (NPC1) disease is sensorineural